![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Found 34 studies with search of: | "Mucopolysaccharidoses" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|
||||
2 | Recruiting |
Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I
|
||||
3 | Completed |
Stem Cell Transplantation for Hurler
|
||||
4 |
Completed Has Results |
Study of rhASB in Patients With Mucopolysaccharidosis VI
|
||||
5 |
Completed Has Results |
Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease
|
||||
6 | Completed |
A Dose-Optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease
|
||||
7 | Completed |
Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients
|
||||
8 | Recruiting |
A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants
|
||||
9 | Completed |
Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene Into Lymphocytes of Patients With Mucopolysaccharidosis II (Mild Hunter Syndrome)
|
||||
10 | Completed |
Iduronate-2-Sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)
|
||||
11 | Not yet recruiting |
A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I
|
||||
12 | Recruiting |
Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I
|
||||
13 | Recruiting |
Immune Tolerance Study With Aldurazyme®
|
||||
14 | Recruiting |
Mucopolysaccharidosis I (MPS I) Registry
|
||||
15 | Recruiting |
A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG Levels in Aldurazyme® Treated Patients
|
||||
16 | Completed |
A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old
|
||||
17 | Recruiting |
A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)
|
||||
18 | Recruiting |
A Study to Evaluate the Safety, Tolerability and Efficacy of BMN 110 in Subjects With Mucopolysaccharidosis IVA
|
||||
19 | Recruiting |
A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI
|
||||
20 | Completed |
Open-Label Study of Efficacy and Safety of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI
|
![]() |
Previous Page | Studies Shown (1-20) | Next Page (21-34) |
![]() |